WHO's Six Principles for Artificial Intelligence in Health
WHO's six AI ethics principles become useful when translated into concrete design, procurement, deployment, monitoring, and redress controls.
Health & Evidence Library
Clear explanations of clinical software, algorithms, data quality, validation, monitoring, privacy, and safe human oversight.
48 guides · Page 1 of 1
WHO's six AI ethics principles become useful when translated into concrete design, procurement, deployment, monitoring, and redress controls.
Large health datasets shrink random error but can preserve bias, weak proxies, leakage, missingness, and drift with impressive precision.
Safe health AI needs a tested abstention pathway for unfamiliar, incomplete, conflicting, or uncertain cases, plus a reliable human fallback.
A practical reading of WHO's guidance on governing generative AI that can process text, images, audio, or video in health settings.
Time in range summarizes continuous glucose monitor readings within a defined interval. Learn the standard metrics, evidence, limits, and safe interpretation.
A patient-facing AI explanation should clarify purpose, inputs, basis, uncertainty, options, accountability, and recourse, not merely display model internals.
Health economics examines scarcity, opportunity cost, incentives, equity, and how costs and outcomes change when health systems choose among alternatives.
Foundation models can be adapted across medical tasks, but broad pretraining does not establish clinical validity, safety, regulation, or patient benefit.
Decision-curve analysis tests whether using a model could improve decisions across plausible thresholds while making assumptions and limits visible.
Why clinical models overfit, how optimism appears, and which validation practices reveal whether performance will travel beyond development data.
Prediction models can fail elsewhere when populations, measurements, workflows, treatments, and outcome definitions change.
Prediction estimates what is likely to happen; explanation asks why. Clinical models need a question, design, and validation matched to that purpose.
Durable digital health depends on clinical need, evidence, workflow fit, operations, governance, adaptation, and continued measurement.
Medical AI explanations need a defined audience, tested fidelity, stability, limits, and evidence that they support appropriate human decisions.
A decision threshold turns a predicted risk into an action and encodes how a clinical setting weighs missed cases against unnecessary intervention.
Validation tests a product claim under defined conditions. Marketing translates evidence into a message that can be accurate, selective, or misleading.
False positives can trigger repeat tests, procedures, anxiety, labeling, alert burden, and delayed care. Their real cost depends on the full workflow.
How current reporting guidelines make medical AI claims checkable across prediction, diagnosis, trials, imaging, and early clinical evaluation.
How retrospective, prospective silent-mode, and interventional studies answer different questions about clinical AI performance and value.
How a PCCP can authorize bounded future changes to an AI-enabled medical device, and what reviewers should expect from its methods, safeguards, and monitoring.
A practical framework for monitoring medical AI after deployment, including drift, subgroup performance, workflow, updates, safety, and action thresholds.
Clinical model monitoring links data, performance, workflow, subgroup, and safety signals to predefined investigation and response paths.
How ROC thresholds trade sensitivity for specificity, what AUC measures, and why calibration, validation, prevalence, and utility still matter.
Learn how calibration plots compare predicted risk with observed outcomes, what the diagonal means, and why discrimination alone is not enough.
Appraise a clinical prediction model by checking its purpose, data, calibration, discrimination, transportability, and decision value.
Apply EU MDR Rule 11 only after qualification, then use intended purpose, clinical function, decision consequence, and the strictest applicable rule.
What interoperability means in healthcare, why it is so hard, and why it often determines whether a digital health tool actually helps clinicians and patients.
New experiments show a wrong but confident AI suggestion can drag a trained clinician's reasoning below no help at all. Here is what they measured.
CGM reliably improves glucose control for people on insulin. For most other claims the evidence is thinner. Here is how to read them.
What the Joint Commission and CHAI responsible-AI guidance asks hospitals to do, and the questions that reveal whether a program is real or on paper
A six-question checklist for judging whether a clinical AI tool is safe to deploy: purpose, evidence, validation, transparency, monitoring, and accountability.
What a health AI model card is, and how a voluntary CHAI nutrition label differs from binding FDA device labeling.
A plain-language guide to how insulin pumps and closed-loop artificial pancreas systems work, and why automating small dosing decisions holds glucose steadier.
Why clinical AI works best when a trained person keeps the authority to review, override, and own every decision before it reaches a patient.
How to evaluate ambient AI scribe tools by omission, fabrication, certainty drift, and note bloat, using randomized and scoping evidence, not time saved.
How to judge an AI symptom checker: what it is for, how it treats uncertainty, and whether it points you toward care when it matters.
How FDA and its advisers weigh therapy-style AI chatbots, and why hallucination, sycophancy, and automation bias shape the oversight debate
AI speeds up the front of the drug pipeline, targets, molecules, and property prediction. Here is where those gains stop and why human trials still decide.
A plain explainer of the FDA, Health Canada, and MHRA joint Good Machine Learning Practice principles for medical AI.
Why clinical AI usually loses accuracy at new sites and in later years, and how to tell a real external test from a reassuring-sounding one.
How to check a clinical algorithm serves every patient group, using representative data, subgroup testing, and post-launch monitoring.
How clinical decision support works inside a real diabetes visit, what the trial evidence shows, and how to tell a useful tool from a demo.
Clinical AI rises or falls on its data. What trustworthy clinical data looks like, and why the flaws stay invisible until the tool reaches real patients.
Accuracy tells you how often a model is right. Calibration tells you whether its probabilities are true. Acting on a number needs calibration.
What happens to your health data, the basic rights you have over it, and a sensible, non-anxious way to think about health privacy.
A plain, brand-neutral guide to the main diabetes technologies, what they do, and how to judge them by evidence and fit rather than marketing.
Where the evidence for artificial intelligence in healthcare is genuinely strong, where it is still thin, and how to read claims about it honestly.
What clinical decision support is, what the evidence shows, where alert fatigue bites, and why these tools support rather than replace a clinician's judgment.